Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Zang

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Statistics in Medicine|August 28, 2020
BILITE: A Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacyBeibei Guo, Yong Zang
Statistics in Medicine|September 20, 2016
Optimal sequential enrichment designs for phase II clinical trialsYong Zang, Ying Yuan
Statistical Methods in Medical Research|February 22, 2022
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapyBeibei Guo, Yong Zang
Statistical Methods in Medical Research|December 22, 2020
CWL: A conditional weighted likelihood method to account for the delayed joint toxicity-efficacy outcomes for phase I/II clinical trialsYifei Zhang, Yong Zang
Genes|November 27, 2021
CMAX3: A Robust Statistical Test for Genetic Association Accounting for CovariatesZhongxue Chen, Yong Zang
Statistical Methods in Medical Research|September 20, 2018
A Bayesian adaptive phase II clinical trial design accounting for spatial variationBeibei Guo, Yong Zang
Statistics in Medicine|November 25, 2021
BIPSE: A biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpointBeibei Guo, Yong Zang
Genetic Epidemiology|August 13, 2013
A shrinkage method for testing the Hardy-Weinberg equilibrium in case-control studiesYong Zang, Ying Yuan
Statistical Methods in Medical Research|November 29, 2015
Optimal two-stage enrichment design correcting for biomarker misclassificationYong Zang, Beibei Guo
Genetic Epidemiology|October 20, 2011
Robust Mantel-Haenszel test under genetic model uncertainty allowing for covariates in case-control association studiesYong Zang, Wing Kam Fung
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Statistics in Medicine|August 28, 2020
BILITE: A Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacyBeibei Guo, Yong Zang
Statistics in Medicine|September 20, 2016
Optimal sequential enrichment designs for phase II clinical trialsYong Zang, Ying Yuan
Statistical Methods in Medical Research|February 22, 2022
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapyBeibei Guo, Yong Zang
Statistical Methods in Medical Research|December 22, 2020
CWL: A conditional weighted likelihood method to account for the delayed joint toxicity-efficacy outcomes for phase I/II clinical trialsYifei Zhang, Yong Zang
Genes|November 27, 2021
CMAX3: A Robust Statistical Test for Genetic Association Accounting for CovariatesZhongxue Chen, Yong Zang
Statistical Methods in Medical Research|September 20, 2018
A Bayesian adaptive phase II clinical trial design accounting for spatial variationBeibei Guo, Yong Zang
Statistics in Medicine|November 25, 2021
BIPSE: A biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpointBeibei Guo, Yong Zang
Genetic Epidemiology|August 13, 2013
A shrinkage method for testing the Hardy-Weinberg equilibrium in case-control studiesYong Zang, Ying Yuan
Statistical Methods in Medical Research|November 29, 2015
Optimal two-stage enrichment design correcting for biomarker misclassificationYong Zang, Beibei Guo
Genetic Epidemiology|October 20, 2011
Robust Mantel-Haenszel test under genetic model uncertainty allowing for covariates in case-control association studiesYong Zang, Wing Kam Fung
Pageof 11